TAF3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.004600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.131200E-01
Normal-vs-Stage2
1.103980E-01
Normal-vs-Stage3
1.363430E-01
Normal-vs-Stage4
9.467400E-01
Stage1-vs-Stage2
4.658600E-01
Stage1-vs-Stage3
8.207900E-02
Stage1-vs-Stage4
4.397200E-01
Stage2-vs-Stage3
1.595590E-01
Stage2-vs-Stage4
8.843500E-02
Stage3-vs-Stage4
8.872000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.009030E-01
Normal-vs-AfricanAmerican
4.926400E-01
Normal-vs-Asian
5.606000E-02
Caucasian-vs-AfricanAmerican
4.195000E-01
Caucasian-vs-Asian
8.737900E-02
AfricanAmerican-vs-Asian
1.467240E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.054980E-01
Normal-vs-Female
1.084580E-01
Male-vs-Female
9.199000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.340400E-01
Normal-vs-Age(41-60Yrs)
2.934600E-01
Normal-vs-Age(61-80Yrs)
6.265800E-02
Normal-vs-Age(81-100Yrs)
2.165900E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.257000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.990800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.768400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
9.163300E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.734000E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.706000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.177700E-02
Normal-vs-Daily Drinker
3.385900E-02
Normal-vs-Weekly Drinker
2.190000E-01
Normal-vs-Occasional Drinker
7.959900E-02
Normal-vs-Social Drinker
1.815830E-01
Non Drinker-vs-Daily Drinker
6.271200E-01
Non Drinker-vs-Weekly Drinker
4.345600E-01
Non Drinker-vs-Occasional Drinker
6.534000E-01
Non Drinker-vs-Social Drinker
4.651800E-01
Daily Drinker-vs-Weekly Drinker
2.817600E-01
Daily Drinker-vs-Occasional Drinker
3.966000E-01
Daily Drinker-vs-Social Drinker
2.948000E-01
Weekly Drinker-vs-Occasional Drinker
7.176000E-01
Weekly Drinker-vs-Social Drinker
9.485200E-01
Occasional Drinker-vs-Social Drinker
7.629000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.177400E-01
Normal-vs-Grade 2
7.202400E-02
Normal-vs-Grade 3
6.877600E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.205240E-01
Grade 1-vs-Grade 3
1.384360E-01
Grade 1-vs-Grade 4
2.177400E-01
Grade 2-vs-Grade 3
9.072000E-01
Grade 2-vs-Grade 4
7.202400E-02
Grade 3-vs-Grade 4
6.877600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.191620E-01
Normal-vs-NonDiabetic
3.376300E-02
Diabetic-vs-NonDiabetic
2.017000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.513900E-02
Normal-vs-NoPancreatitis
5.920300E-02
Pancreatitis-vs-NoPancreatitis
6.587600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.159780E-01
Normal-vs-N1
1.084390E-01
N0-vs-N1
4.483400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.909800E-01
Normal-vs-TP53-NonMutant
3.122800E-01
TP53-Mutant-vs-TP53-NonMutant
9.017600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
